ARGATROBAN (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the ARGATROBAN drug offered from GlaxoSmithKline LLC. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | argatroban |
SUBSTANCE NAME: | ARGATROBAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2000-11-28 |
END MARKETING DATE: | 0000-00-00 |
ARGATROBAN HUMAN PRESCRIPTION DRUG Details:
Item Description | ARGATROBAN from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2000-11-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0007-4407_334cd1c6-10af-4aaf-abfd-603b6eb3a832 |
PRODUCT NDC: | 0007-4407 |
APPLICATION NUMBER: | NDA020883 |
Other ARGATROBAN Pharmaceutical Manufacturers / Labelers: